Lou Reese

Entrepreneur and biotech executive focused on synthetic peptide-based active immunotherapies, co-CEO of United Biomedical and co-founder of Vaxxinity, Cana Life, and Axxium, involved in developing vaccine and neurodegenerative disease candidates.

Best podcasts with Lou Reese

Ranked by the Snipd community

Jan 23, 2026 • 48min

A New Approach to Alzheimer’s? | Lou Reese

Lou Reese, a biotech entrepreneur and co-CEO of United Biomedical, dives into groundbreaking innovations in immunotherapy for Alzheimer's and Parkinson's. He discusses a synthetic peptide-based treatment that could revolutionize Alzheimer’s care. Lou also shares his intriguing experience with a peptide vaccine for COVID-19, which faced hurdles despite promising trial results. His insights shed light on the complex interactions between vaccine development and market competition, highlighting the need for transparency in medical research.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app